Zimmer Biomet Holdings (ZBH)
ZBHZimmer Biomet Holdings
-$0.055 (-0.03%)

Zimmer Biomet Holdings Stock Analysis & Ratings

Zimmer Biomet Holdings Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The Zimmer Biomet Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, Data-Driven rating system and does not include human intervention.

Stock Chart

-$0.055 (-0.03%)

ZBH Stock Stats

Previous Close$157.55
Bid157.2 x 33
Ask157.64 x 1
Today’s Range$0 - $0
52-Week Range$112.00 - $180.36
Average Volume1.17M
Market Cap$32.83B
P/E Ratio58.2
Earnings DateJul 29, 2021
Dividend & Yield0.96 (0.61%)
Ex-Dividend DateJun 25, 2021

Company Description

Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing, craniomaxillofacial and thoracic products; and related surgical products.
Medical Devices & Instruments
Bryan C. Hanson
345 East Main Street, Warsaw, IN, 46580, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was $112.00 and its highest was $180.36 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Zimmer Biomet Holdings’s market cap is $32.83B.
What is Zimmer Biomet Holdings’s price target?
The average price target for Zimmer Biomet Holdings is $194.25. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $210.00 ,the lowest forecast is $160.00. The average price target represents 23.34% Increase from the current price of $157.495.
What do analysts say about Zimmer Biomet Holdings?
Zimmer Biomet Holdings’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is Jul 29, 2021 which is next month.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on May 04, 2021. The company reported $0.942 earnings per share for the quarter, missing the consensus estimate of $1.528 by -$0.586.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of $0.24 which represents an annual dividend yield of 0.61%. Zimmer Biomet Holdings’s last Quarterly dividend payment was on Jul 30, 2021. Zimmer Biomet Holdings’s upcoming ex-dividend date is Jun 25, 2021
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 208,480,000 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of $0.942 in its last earnings report, missing expectations of $1.528. Following the earnings report the stock price went down -2.467%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Among the largest hedge funds holding Zimmer Biomet Holdings’s share is PRIMECAP Management Co. It holds Zimmer Biomet Holdings’s shares valued at 562M.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis